BO
BioLattice Ophthalmics, Inc,
SEC filingBiotechnology · Philadelphia, PA
Amount raised$575Ksold at filing
Total offering$2.5M$1.9M still open
Investors in the raise2count reported to the SEC
FiledMar 30, 2026first sale Mar 6, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Gregory JacksonDirector
Amelia ZellanderExecutive Officer, Director
Linda AlunkalExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.